Search research articles
Contact Us
Filters
Showing results (141-150 of 291) with videos related to
Page
of 30
Sort By:
JAMA Oncology
|
May 16, 2024
Physician and Artificial Intelligence Chatbot Responses to Cancer Questions From Social Media
David Chen, Rod Parsa, Andrew Hope, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer
Marie C Chia, Abby Leung, Tiffany Krushel, et al.
Journal of Infection and Public Health
|
July 25, 2019
Association of the infectious triggers with childhood Henoch-Schonlein purpura in Anhui province, China
Jing Jing Wang, Yao Xu, Fei Fei Liu, et al.
Pharmacoeconomics - Open
|
August 31, 2023
Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma
Elisabeth F P Peterse, Elisabeth J M Verburg-Baltussen, Alexa Stewart, et al.
Experimental Hematology & Oncology
|
March 26, 2022
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel
Guillaume Cartron, Christopher P Fox, Fei Fei Liu, et al.
Oncogenesis
|
May 26, 2018
Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Jacqueline H Law, Jeff P Bruce, et al.
Journal of Hazardous Materials
|
April 6, 2010
Characteristics and mechanisms of Cu(II) biosorption by disintegrated aerobic granules
Xin-Hua Wang, Rui-Hong Song, Shao-Xiang Teng, et al.
Molecular Cancer Therapeutics
|
September 21, 2006
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent
Kenneth W Yip, Emma Ito, Xinliang Mao, et al.
BMC Cancer
|
June 27, 2020
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Mona Teng, Jacqueline H Law, et al.
Plos One
|
May 24, 2014
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma
Justin P Williams, Inki Kim, Emma Ito, et al.
Page
of 30
Search research articles
Search
Showing results (141-150 of 291) with videos related to
Sort By:
Page
of 30
JAMA Oncology
|
May 16, 2024
Physician and Artificial Intelligence Chatbot Responses to Cancer Questions From Social Media
David Chen, Rod Parsa, Andrew Hope, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer
Marie C Chia, Abby Leung, Tiffany Krushel, et al.
Journal of Infection and Public Health
|
July 25, 2019
Association of the infectious triggers with childhood Henoch-Schonlein purpura in Anhui province, China
Jing Jing Wang, Yao Xu, Fei Fei Liu, et al.
Pharmacoeconomics - Open
|
August 31, 2023
Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma
Elisabeth F P Peterse, Elisabeth J M Verburg-Baltussen, Alexa Stewart, et al.
Experimental Hematology & Oncology
|
March 26, 2022
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel
Guillaume Cartron, Christopher P Fox, Fei Fei Liu, et al.
Oncogenesis
|
May 26, 2018
Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Jacqueline H Law, Jeff P Bruce, et al.
Journal of Hazardous Materials
|
April 6, 2010
Characteristics and mechanisms of Cu(II) biosorption by disintegrated aerobic granules
Xin-Hua Wang, Rui-Hong Song, Shao-Xiang Teng, et al.
Molecular Cancer Therapeutics
|
September 21, 2006
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent
Kenneth W Yip, Emma Ito, Xinliang Mao, et al.
BMC Cancer
|
June 27, 2020
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Mona Teng, Jacqueline H Law, et al.
Plos One
|
May 24, 2014
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma
Justin P Williams, Inki Kim, Emma Ito, et al.
Page
of 30